AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 141 min read$CHYM

Feuille James sold $11.6M of CHYM (indirect holdings)

Feuille James sold 351,890 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $33.00 ($32.89–$33.15, $11.61M total) across 3 trades over 2026-09-10 to 2026-09-11.

Original reporting
SEC EDGAR · Feuille James
Published Sep 14, 2026, 9:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CHYM
Bearish
medium confidence
Mentioned
$CHYM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMBearishLow
01

Why it matters

The director's sale represents the first report of a material insider divestiture for CHYM this quarter.

02

Market read

First‑report insider sale of over $10M may influence short‑term price action and sentiment toward CHYM.

03

What to watch

Potential upcoming earnings or product news that could offset the negative signal.

Relevance 7/10Novelty 5/10Timing: Filed Sep 14 2026 (Form 4)

Background

SEC Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$CHYMBearishMedium confidence
Context

Director Feuille James sold $11.6M of CHYM shares via open‑market trades on Sep 10‑11, 2026.

Expected impact

Short‑term downward pressure; traders may consider a modest sell or hedge.

Evidence & confidence

A $11.6M sale by a director is material but not extraordinary; market reaction typically modest.

Market effects

Sector

May raise concerns for fintech sector if other insiders follow suit.

Regional

Limited to U.S. markets where CHYM trades.

Global

Minimal; impact confined to CHYM and possibly comparable digital‑bank stocks.

Counterpoint

What could challenge this read

The sale could be a routine liquidity move unrelated to company fundamentals.

Key entities

  • Director
    Feuille James

    Insider who sold 351,890 CHYM shares.

  • Company
    Chime Financial, Inc.

    Fintech lender listed on Nasdaq under ticker CHYM.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CHYM insider trading history →

Related articles

OCT 8
$CHYMHigh

Why is Chime Financial stock gaining today?

Chime Financial (CHYM) stock rose 1.5% in pre-market trading after Deutsche Bank upgraded it to Buy and raised its price target to $35. The bank cited strong Q2 2026 results, including 27% revenue growth and GAAP profitability, as well as growth in MyPay and Chime Prime. The upgrade also boosted FY27 adjusted EBITDA estimates by $71 million.

investing.com2 min
OCT 8
$CHYMMed

Deutsche Bank Upgrades Chime (CHYM) to Buy, Raises Price Target

Deutsche Bank upgraded Chime Financial Inc (CHYM) to Buy, raising its price target to $35. The bank cited strong product momentum and market expansion potential, particularly with MyPay and Chime Prime. Chime's P/S ratio is 4.85, above its historical and industry medians, reflecting growth expectations. Insider activity shows significant net selling, while institutional ownership trends are mixed.

gurufocus.com2 min
SEP 23
$CHYMMed

Chime Financial Slides as Recent Insider Sales Likely Weigh on Shares

Chime Financial (CHYM) shares fell 7.5% today, likely due to recent insider and major-holder sales, including 3.2 million shares sold by DST Global and 447,637 shares by director James Feuille. The decline follows Chime's announcement of a $590 million bank acquisition, with no new negative updates reported. Analysts' median price target for CHYM is $28.0.

quiverquant.com2 min